Table 1.
Enrolled in Study (N=19) | Completed Study (N=15) | |
---|---|---|
Median age at enrollment, years ±SD | 45±11 | 49±11 |
Male Sex, % | 74% | 73% |
Median BMI, ±SD | 25±5 | 24±5 |
Race | ||
Caucasian | 14 | 11 |
African American | 3 | 2 |
Other | 2 | 2 |
PSC Classification | ||
Large-duct | 12 | 9 |
Small-duct | 7 | 6 |
Inflammatory Bowel Disease | 15 | 12 |
Ulcerative Colitis | 13 | 11 |
Crohn's Disease | 2 | 1 |
Median Mayo PSC Risk Score* ±SD | −0.03±0.71 | −0.05±0.59 |
Median daily dose of UDCA, mg/kg ±SD | 16±6 | 16±7 |
Mayo PSC Risk Score Formula: R = 0.03 (age [y]) + 0.54 loge (bilirubin [mg/dL]) + 0.54 loge (aspartate aminotransferase [U/L]) + 1.24 (variceal bleeding [0/1]) - 0.84 (albumin [g/dL]).